Biomarker Technologies Market Overview by Size, Share, Top Trends, Major Players and Forecast to 2023

MRFR Offers a Thorough Analysis of "Global Biomarker Technologies Market 2019 ". The primary objective of the report is to analyze the current market landscape and its future potential.

Pune, India - July 18, 2019 /MarketersMedia/ —

Biomarker Technologies Market Global Players:

Abbott Laboratories, Agilent Technologies (U.S.), Thermo Fisher Scientific (U.S.), Roche (Switzerland), Waters Corporation (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Siemens Healthcare, and Bio-Rad Laboratories (U.S.).


The global biomarker technologies market is segmented on the basis of product type, profiling technology, disease application, and research areas. Considering product type, the market is segmented into consumables, instruments, services, and software/informatics.

By profiling technology, the market is segmented into immunoassay, PCR, imaging technology, mass spectrometry, NGS, chromatography, cytogenetics, and other technologies. Based on immunoassay, the market is again segmented into ELISA, western blot, and protein microarray.

Request Free Sample Copy at

With reference to disease application, the market is segmented into cancer, infectious disease, autoimmune diseases, neurological, cardiovascular disorders, and other disorders.

On account of research areas, the market is segmented into Genomics, Proteomics, Metabolomics, and other research areas. Metabolomics is further segmented into lipidomic and others.

Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.

Biomarker Technologies Market Global Overview:

The biomarker technologies market is growing pervasively at the rapid pace; mainly due to the increased research and development activities that are driven by substantial investments.  Simultaneously, the rising demand for diagnosis and treatment of diseases associated with the old age escalates the market growth on the global platform.

Acknowledging the accruals, the market is garnering currently, Market Research Future (MRFR) in its recently published study report, asserts that the growth of the global biomarker technologies will reach USD 78 BN by 2023, registering a staggering CAGR of 9 % from 2018 to 2023. 

Additional factors fostering the market growth include the widened uptake of biomarkers technologies, increasing research and development activities transpired into the field of biomarker test, growing number of contract research organizations and the cost-effective clinical trials. The spreading awareness towards the effective diagnosis processes along with the growing demand for personalized medicine is contributing to the market growth to an extent.

On the other hand, high capital investments required for the discovery, development of biomarkers, and the high cost of biomarkers are some of the factors obstructing the market growth. Nevertheless, government grants and initiatives that are undertaken to increase the R&D activities in the field are expected to support the market growth.

Regional Analysis:

The North American region dominates the global biomarker technology market. Heading with the rapid research and development initiatives, the market is expected to create a large revenue pocket over the forecast period. Factors substantiating the market growth include substantial investments in the R&D activities in the field of diagnosis, prognostic treatments, and drug formulation.

Furthermore, the increasing prevalence of cancer, cardiovascular, autoimmune and neurological diseases alongside the rising geriatric population are positively impacting the market growth in the region. Additional factors such as high healthcare expenditures, increasing government initiatives and funding for research, development to discover advanced medical treatment options, and the availability of favorable reimbursement policies are expected to propel the market growth in the region.

Europe accounts for the second-largest market for biomarker technologies. With the availability of advanced treatment facilities and established healthcare infrastructure and the growing demand for accurate diagnosis, the market is expected to register a considerable CAGR. Besides, factors such as favorable governmental support and initiatives propel the market growth in the region.

The proliferating healthcare sector heading with the resurging economy is fostering the market growth brilliantly. The rising incidences of cancer are expected to impact on the biomarker technologies market positively.

Whereas, the Asia Pacific biomarker technologies market is proliferating, emerging as one of the promising markets, globally. Asian countries especially, India and China provide immense growth opportunities for the biomarker technologies market, accounting for the huge population.  Additionally, factors such as the increasing prevalence of chronic diseases are the major driving forces for the market growth.

Furthermore, factors such as the increasing patient pool, raising awareness about healthcare, and the availability of new treatment methods are fostering the market growth in the region. Also, rising healthcare expenditure and improvement in the standard of living due to the improving economic conditions in the region are propelling the growth of biomarker technologies market in the APAC.


Report Prologue
Market Introduction
2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Research Methodology
3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Market Dynamics

List of Tables:

Table 1 Biomarker Technologies Industry Synopsis, 2018–2023

Table 2 Global Biomarker Technologies Market Estimates And Forecast, 2018–2023, (USD Million)

Table 3 Global Biomarker Technologies Market, By Region, 2018–2023, (USD Million)

Table 4 Global Biomarker Technologies Market, By Profiling Technology, 2018–2023, (USD Million)

Table 5 Global Biomarker Technologies Market, By Product, 2018–2023, (USD Million)

Table 6 Global Biomarker Technologies Market, By Disease Application, 2018–2023, (USD Million)

Table 7 Global Biomarker Technologies Market, By Research Areas, 2018–2023, (USD Million)

Table 8 North America Biomarker Technologies Market, By Profiling Technology, 2018–2023, (USD Million)

Table 9 North America Biomarker Technologies Market, By Disease Application, 2018–2023, (USD Million)

Table 10 North America Biomarker Technologies Market, By Product, 2018–2023, (USD Million)


Browse Full Report at

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Abhishek Sawant
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 6468459312

Source URL:

Source: MarketersMedia

Release ID: 88898421

Latest News

China announces tariff hike on $75 billion of US products

Aug 24, 2019

BEIJING — China on Friday announced tariff hikes on $75 billion of U.S. products in retaliation for President Donald Trump's latest planned increase, deepening a conflict over trade and technology that threatens to tip a weakening global economy into recession. China also will increase import duties on U.S.-made autos and auto parts, the Finance Ministry announced. The announcement comes as leaders of the Group of 7 major economies prepare to meet in France this weekend. Tariffs of 10% and 5% will take effect on two batches of goods on Sept. 1 and Dec. 15, the ministry said in a statement....

Global stocks higher ahead of US Fed chairman's speech

Aug 24, 2019

BEIJING — Global stock markets rose Friday after Wall Street declined ahead of a closely watched speech by the U.S. Federal Reserve chairman. Market benchmarks in London, Frankfurt, Shanghai and Tokyo all advanced. Investors are looking to Jerome Powell's speech Friday for signs of direction on interest rates after two regional Fed presidents said they see no need for a change. Investors expect a cut in September, the Fed's second in three months, to shore up U.S. economic growth amid a tariff war with Beijing and weakening global growth. "Markets seem very clearly positioned for some very dovish guidance from...

Japan leader says S. Korea ending intel deal damages trust

Aug 24, 2019

TOKYO — Japanese Prime Minister Shinzo Abe said South Korea's decision to cancel a deal to share military intelligence is damaging mutual trust, and he vowed Friday to work closely with the U.S. for regional peace. Abe also accused Seoul of not keeping past promises. The military agreement started in 2016. "We will continue to closely coordinate with the U.S. to ensure regional peace and prosperity, as well as Japan's security," he said, ahead of his departure for the Group of Seven summit of industrialized nations in France. South Korea announced Thursday it would terminate the intelligence deal because Tokyo's...

Women, late-in-life new authors expand Japanese literature

Aug 24, 2019

TOKYO — The works receiving one of Japan's most coveted literary awards, the Naoki Prize, have something new in common: For the first time in 85 years, all six of the nominated authors are women. Japan is home to what many consider the world's first novel, "The Tale of Genji," written in the 11th century by noblewoman Murasaki Shikibu. Its modern fiction has been defined mostly by long-established male writers such as past Nobel laureates Kenzaburo Oe and Yasunari Kawabata. And for decades it has been dominated by Haruki Murakami, whose surreal blend of magical realism and pop culture has...

S. Korea cancels Japan intelligence deal amid trade dispute

Aug 24, 2019

SEOUL, South Korea — South Korea said Thursday it will terminate an intelligence-sharing deal with Japan that focused on classified information about North Korea, a surprise announcement that is likely to set back U.S. efforts to bolster security cooperation with two of its most important allies in the Asian region. South Korea attributed the decision to its bitter trade dispute with Japan, which has plunged the two countries' relations to their lowest point since they established diplomatic ties in 1965. Japanese Foreign Minister Taro Kono called the decision "extremely regrettable" and summoned the South Korean ambassador to protest the linking...

Subscribe To Our Newsletter